Welcome to our dedicated page for Pasinex Res news (Ticker: PSXRF), a resource for investors and traders seeking the latest updates and insights on Pasinex Res stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Pasinex Res's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Pasinex Res's position in the market.
Pasinex Resources (OTC: PSXRF) reported audited results for the fifteen-month period ended March 31, 2026, reflecting a transitional year marked by major acquisitions and balance sheet changes. Revenue was C$1,000,809, all from Horzum after it became a wholly owned subsidiary, while the consolidated net loss widened to C$5,756,253 (C$0.032 per share).
According to Pasinex, 2025 was transformational as it acquired the remaining 50% of Horzum, gaining full control of the producing Pinargozu zinc mine, and bought Aydin Teknik, holder of the Sarikaya lead-zinc licence, for US$2.6 million. Total assets rose to C$8.8 million and shareholders’ equity moved from a C$1.3 million deficiency to positive C$3.6 million, helped by reducing shareholder loans to C$1.9 million and settling about C$5.5 million of debt via issuing roughly 62.2 million shares.
Subsequent to period end, Pasinex closed an oversubscribed private placement for C$2,014,880 and received C$275,000 from the exercise of 6,875,000 stock options.